Table 3: Number of users and their reporting limits for the immunoassays used. (participants in EQA round 2020:01 [article number: KSP 014], Equalis AB, Uppsala, Sweden)
[ATTACH=full]35637[/ATTACH]
[ATTACH=full]35638[/ATTACH]
[ATTACH=full]35639[/ATTACH]
